Ticker
ATRACompany Name
ATARA BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 16.9M | 1.16 | $ 14.56M |
3/31/2025 | $ 13.99M | 0.29 | $ 47.89M |
12/31/2024 | $ 25.18M | 0.19 | $ 134.57M |
9/30/2024 | $ 46.6M | 0.3 | $ 155.98M |
6/30/2024 | $ 31.46M | 0.21 | $ 148.27M |
3/31/2024 | $ 35.23M | 0.19 | $ 180.69M |
12/31/2023 | $ 25.99M | 0.18 | $ 142.23M |
9/30/2023 | $ 64.94M | 0.82 | $ 79.09M |
6/30/2023 | $ 46.04M | 0.62 | $ 74.55M |
3/31/2023 | $ 48.89M | 0.72 | $ 67.88M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for ATARA BIOTHERAPEUTICS INC is calculated as follows: CashnEq [ $ 62.81M ] / LiabilitesC [ $ 36.05M ]
(=) Cash Ratio [ 1.74 ]
Minimum
Dec 31, 2023
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |